Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
Background Glioblastoma is the most aggressive primary malignant brain tumor in adults and is characterized by poor prognosis. Immune evasion occurs via programmed death-ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) interaction. Some malignant tumors have responded to PD-L1/PD-1 blockade treat...
Guardado en:
Autores principales: | Dina Mohamed El Samman, Manal Mohamed El Mahdy, Hala Sobhy Cousha, Zeinab Abd El Rahman Kamar, Khaled Abdel Karim Mohamed, Hoda Hassan Abou Gabal |
---|---|
Formato: | article |
Lenguaje: | EN KO |
Publicado: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/791d96d5a4c74fff91e581c3a53bb312 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas E, et al.
Publicado: (2017) -
Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Wanli Yu, et al.
Publicado: (2021) -
Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma
por: Jinkun Han, et al.
Publicado: (2021) -
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
por: Kirit Singh, et al.
Publicado: (2021) -
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
por: Chih-Yang Huang, et al.
Publicado: (2018)